Literature DB >> 25981510

Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.

Jonathan H Chung1, Jinlu Cai2, Barrie G Suskin3, Zhengdong Zhang1, Karlene Coleman4, Bernice E Morrow1.   

Abstract

The 22q11.2 deletion syndrome (22q11DS) affects 1:4,000 live births and presents with highly variable phenotype expressivity. In this study, we developed an analytical approach utilizing whole-genome sequencing (WGS) and integrative analysis to discover genetic modifiers. Our pipeline combined available tools in order to prioritize rare, predicted deleterious, coding and noncoding single-nucleotide variants (SNVs), and insertion/deletions from WGS. We sequenced two unrelated probands with 22q11DS, with contrasting clinical findings, and their unaffected parents. Proband P1 had cognitive impairment, psychotic episodes, anxiety, and tetralogy of Fallot (TOF), whereas proband P2 had juvenile rheumatoid arthritis but no other major clinical findings. In P1, we identified common variants in COMT and PRODH on 22q11.2 as well as rare potentially deleterious DNA variants in other behavioral/neurocognitive genes. We also identified a de novo SNV in ADNP2 (NM_014913.3:c.2243G>C), encoding a neuroprotective protein that may be involved in behavioral disorders. In P2, we identified a novel nonsynonymous SNV in ZFPM2 (NM_012082.3:c.1576C>T), a known causative gene for TOF, which may act as a protective variant downstream of TBX1, haploinsufficiency of which is responsible for congenital heart disease in individuals with 22q11DS.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  22q11.2 deletion syndrome; integrative analysis; juvenile rheumatoid arthritis; schizophrenia psychosis; tetralogy of Fallot

Mesh:

Year:  2015        PMID: 25981510      PMCID: PMC4514564          DOI: 10.1002/humu.22814

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  80 in total

1.  Arthritis associated with deletion of 22q11.2: more common than previously suspected.

Authors:  G F Keenan; K E Sullivan; D M McDonald-McGinn; E H Zackai
Journal:  Am J Med Genet       Date:  1997-09-05

2.  Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.

Authors:  Efrat Dresner; Galila Agam; Illana Gozes
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-03       Impact factor: 4.600

3.  Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication?

Authors:  S A Rasmussen; C A Williams; E M Ayoub; J W Sleasman; B A Gray; A Bent-Williams; H J Stalker; R T Zori
Journal:  Am J Med Genet       Date:  1996-09-06

4.  Novel ZFPM2/FOG2 variants in patients with double outlet right ventricle.

Authors:  Z-P Tan; C Huang; Z-B Xu; J-F Yang; Y-F Yang
Journal:  Clin Genet       Date:  2011-10-30       Impact factor: 4.438

5.  New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle.

Authors:  Alessandro De Luca; A Sarkozy; R Ferese; F Consoli; F Lepri; M L Dentici; P Vergara; A De Zorzi; P Versacci; M C Digilio; B Marino; B Dallapiccola
Journal:  Clin Genet       Date:  2010-08-02       Impact factor: 4.438

6.  Tetralogy of Fallot with pulmonary atresia associated with chromosome 22q11 deletion.

Authors:  K Momma; C Kondo; R Matsuoka
Journal:  J Am Coll Cardiol       Date:  1996-01       Impact factor: 24.094

7.  Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome.

Authors:  B Morrow; R Goldberg; C Carlson; R Das Gupta; H Sirotkin; J Collins; I Dunham; H O'Donnell; P Scambler; R Shprintzen
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

8.  Kinetochore KMN network gene CASC5 mutated in primary microcephaly.

Authors:  Anne Genin; Julie Desir; Nelle Lambert; Martine Biervliet; Nathalie Van Der Aa; Genevieve Pierquin; Audrey Killian; Mario Tosi; Montse Urbina; Anne Lefort; Frederick Libert; Isabelle Pirson; Marc Abramowicz
Journal:  Hum Mol Genet       Date:  2012-09-13       Impact factor: 6.150

9.  dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations.

Authors:  Xiaoming Liu; Xueqiu Jian; Eric Boerwinkle
Journal:  Hum Mutat       Date:  2013-07-10       Impact factor: 4.878

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  5 in total

1.  Variant discovery and breakpoint region prediction for studying the human 22q11.2 deletion using BAC clone and whole genome sequencing analysis.

Authors:  Xingyi Guo; Maria Delio; Nousin Haque; Raquel Castellanos; Matthew S Hestand; Joris R Vermeesch; Bernice E Morrow; Deyou Zheng
Journal:  Hum Mol Genet       Date:  2016-07-19       Impact factor: 6.150

Review 2.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

3.  Discovery of rare variants implicated in schizophrenia using next-generation sequencing.

Authors:  Raina Rhoades; Fatimah Jackson; Shaolei Teng
Journal:  J Transl Genet Genom       Date:  2019-01-20

4.  Differences between germline and somatic mutation rates in humans and mice.

Authors:  Brandon Milholland; Xiao Dong; Lei Zhang; Xiaoxiao Hao; Yousin Suh; Jan Vijg
Journal:  Nat Commun       Date:  2017-05-09       Impact factor: 14.919

5.  OGDHL Variant rs2293239: A Potential Genetic Driver of Chinese Familial Depressive Disorder.

Authors:  Zhi Pan; Hongjun Tian; Tao Fang; Zhidong Liu; Xiangdong Liu; Guangqian Dou; Guoyong Huang; Zhenqing Zhang; Guangdong Chen; Wenqiang Wang; Chuanjun Zhuo
Journal:  Front Psychiatry       Date:  2022-03-18       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.